Suppr超能文献

区分天然与诱导性Foxp3(+)调节性T细胞的研究进展

Advances in distinguishing natural from induced Foxp3(+) regulatory T cells.

作者信息

Lin Xiaohong, Chen Maogen, Liu Ya, Guo Zhiyong, He Xiaoshun, Brand David, Zheng Song Guo

机构信息

Organ Transplant Center, 1st affiliated Hospital of Sun Yat-sen University Guangzhou, 510080, PR China.

出版信息

Int J Clin Exp Pathol. 2013;6(2):116-23. Epub 2013 Jan 15.

Abstract

For more than a decade now, the regulatory T (Treg) cell has widely been considered as a critical subpopulation of T cells which can suppress effector T cell responses as well as suppressing the activity of other immune cells, such as mast cell, dendritic cells, and B cells. Treg cells have been broadly characterized as comprising of two main populations: thymus-derived natural Treg (nTreg) cells, and peripherally generated induced Treg (iTreg) cells. Both subsets have similar phenotypic characteristics and comparable suppressive function against T cell-mediated immune response and diseases. However, both Foxp3 positive Treg subsets exhibit some specific differences such as different mRNA transcripts and protein expression, epigenetic modification, and stability. These subtle differences reinforce the notion that they represent unique and distinct subsets. Accurately distinguishing iTregs from nTregs will help to clarify the biological features and contributions of each Treg subsets in peripheral tolerance, autoimmunity and tumor immunity. One difficult problem is that it has not been possible to distinguish iTregs from nTregs using surface markers until two recent articles were published to address this possibility. This review will focus on very recent advances in using molecular markers to differentiate these Treg subsets.

摘要

十多年来,调节性T(Treg)细胞一直被广泛认为是T细胞的一个关键亚群,它既能抑制效应T细胞反应,也能抑制其他免疫细胞的活性,如肥大细胞、树突状细胞和B细胞。Treg细胞大致可分为两个主要群体:胸腺来源的天然Treg(nTreg)细胞和外周产生的诱导性Treg(iTreg)细胞。这两个亚群具有相似的表型特征,并且在针对T细胞介导的免疫反应和疾病方面具有相当的抑制功能。然而,两个Foxp3阳性Treg亚群都表现出一些特定差异,如不同的mRNA转录本和蛋白质表达、表观遗传修饰以及稳定性。这些细微差异强化了它们代表独特且不同亚群的观点。准确区分iTreg和nTreg将有助于阐明每个Treg亚群在外周耐受、自身免疫和肿瘤免疫中的生物学特征及作用。一个难题是,直到最近发表的两篇文章探讨了这种可能性之前,一直无法使用表面标志物区分iTreg和nTreg。本综述将聚焦于利用分子标志物区分这些Treg亚群的最新进展。

相似文献

1
Advances in distinguishing natural from induced Foxp3(+) regulatory T cells.
Int J Clin Exp Pathol. 2013;6(2):116-23. Epub 2013 Jan 15.
2
Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans.
J Immunol. 2013 Mar 1;190(5):2001-8. doi: 10.4049/jimmunol.1201379. Epub 2013 Jan 28.
3
Natural and inducible Tregs in swine: Helios expression and functional properties.
Dev Comp Immunol. 2015 Apr;49(2):323-31. doi: 10.1016/j.dci.2014.12.005. Epub 2014 Dec 12.
4
Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
Ann Rheum Dis. 2013 Sep 1;72(9):1549-58. doi: 10.1136/annrheumdis-2012-202216. Epub 2012 Dec 21.
6
Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
Oncotarget. 2016 Mar 22;7(12):14083-94. doi: 10.18632/oncotarget.7334.
8
Induced and thymus-derived Foxp3⁺ regulatory T cells share a common niche.
Eur J Immunol. 2014 Feb;44(2):460-8. doi: 10.1002/eji.201343463. Epub 2013 Oct 30.
9
Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells.
J Immunol. 2015 Apr 15;194(8):3687-96. doi: 10.4049/jimmunol.1401803. Epub 2015 Mar 11.
10
FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.
J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):474-84. doi: 10.1097/QAI.0000000000001000.

引用本文的文献

1
Role of cell-based therapies in digestive disorders: Obstacles and opportunities.
Regen Ther. 2025 Mar 4;29:1-18. doi: 10.1016/j.reth.2025.02.009. eCollection 2025 Jun.
2
The Immunomodulatory Role of Regulatory T Cells in Preterm Birth and Associated Pregnancy Outcomes.
Int J Mol Sci. 2024 Nov 5;25(22):11878. doi: 10.3390/ijms252211878.
3
Regulatory T Cell Dysfunction in Autoimmune Diseases.
Int J Mol Sci. 2024 Jun 29;25(13):7171. doi: 10.3390/ijms25137171.
4
Lipid metabolism in tumor-infiltrating regulatory T cells: perspective to precision immunotherapy.
Biomark Res. 2024 Apr 22;12(1):41. doi: 10.1186/s40364-024-00588-8.
5
Enhancing Regulatory T Cells to Treat Inflammatory and Autoimmune Diseases.
Int J Mol Sci. 2023 Apr 25;24(9):7797. doi: 10.3390/ijms24097797.
6
Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion.
Front Immunol. 2023 Apr 18;14:1161375. doi: 10.3389/fimmu.2023.1161375. eCollection 2023.
7
9
Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis.
J Neuroinflammation. 2022 Dec 19;19(1):306. doi: 10.1186/s12974-022-02667-9.

本文引用的文献

1
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.
J Exp Med. 2012 Oct 22;209(11):2001-16. doi: 10.1084/jem.20111497. Epub 2012 Oct 8.
2
Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.
J Exp Med. 2012 Sep 24;209(10):1713-22, S1-19. doi: 10.1084/jem.20120822. Epub 2012 Sep 10.
3
Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells.
J Exp Med. 2012 Sep 24;209(10):1723-42, S1. doi: 10.1084/jem.20120914. Epub 2012 Sep 10.
5
Helios expression in FoxP3(+) T regulatory cells.
Expert Opin Biol Ther. 2012 Nov;12(11):1423-5. doi: 10.1517/14712598.2012.711310. Epub 2012 Jul 25.
6
Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells.
Ann Rheum Dis. 2012 Sep;71(9):1567-1572. doi: 10.1136/annrheumdis-2011-201052. Epub 2012 Jul 4.
8
Phenotypic and functional properties of Helios+ regulatory T cells.
PLoS One. 2012;7(3):e34547. doi: 10.1371/journal.pone.0034547. Epub 2012 Mar 30.
9
Roles of LAG3 and EGR2 in regulatory T cells.
Ann Rheum Dis. 2012 Apr;71 Suppl 2:i96-100. doi: 10.1136/annrheumdis-2011-200588.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验